共 189 条
[1]
Chatzizisis YS(2010)Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment Drug Saf 33 171-187
[2]
Koskinas KC(2003)Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease Am J Cardiol 91 33-41
[3]
Misirli G(2008)An overview of the extra-lipid effects of rosuvastatin J Cardiovasc Pharmacol Ther 13 157-174
[4]
Vaklavas C(2006)Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 1556-1565
[5]
Hatzitolios A(1999)Natural statins and stroke risk Circulation 99 185-188
[6]
Giannoglou GD(2008)Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2195-2207
[7]
Schneck DW(2010)Statins for community-acquired pneumonia: current state of the science Eur J Clin Microbiol Infect Dis 29 143-152
[8]
Knopp RH(2007)Statins–are they potentially useful in rheumatology? Pol Arch Med Wewn 117 420-425
[9]
Ballantyne CM(2005)Statins and blood coagulation Arterioscler Thromb Vasc Biol 25 287-294
[10]
McPherson R(2009)The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial Intensive Care Med 35 1255-1260